443 related articles for article (PubMed ID: 23927413)
1. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
Bahrami B; Greenwell T; Muecke JS
Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
[TBL] [Abstract][Full Text] [Related]
2. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
Rudkin AK; Dempster L; Muecke JS
Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ocular surface squamous neoplasia with Mitomycin C.
Gupta A; Muecke J
Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
[TBL] [Abstract][Full Text] [Related]
5. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
Lee JH; Kim YH; Kim MS; Kim EC
Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
[TBL] [Abstract][Full Text] [Related]
7. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Zaki AA; Farid SF
Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
[TBL] [Abstract][Full Text] [Related]
9. Ocular surface squamous neoplasia: to cut or not to cut.
Mills RA
Clin Exp Ophthalmol; 2014; 42(4):307-8. PubMed ID: 24890086
[No Abstract] [Full Text] [Related]
10. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
Nemet AY; Sharma V; Benger R
Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
[TBL] [Abstract][Full Text] [Related]
11. Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
Birkholz ES; Goins KM; Sutphin JE; Kitzmann AS; Wagoner MD
Cornea; 2011 Jan; 30(1):37-41. PubMed ID: 20861726
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
13. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
14. Topical chemotherapy for ocular surface squamous neoplasia.
Nanji AA; Sayyad FE; Karp CL
Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
[TBL] [Abstract][Full Text] [Related]
15. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
Akpek EK; Ertoy D; Kalayci D; Hasiripi H
Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
Hirst LW
Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
[TBL] [Abstract][Full Text] [Related]
18. Topical medical therapies for ocular surface tumors.
Poothullil AM; Colby KA
Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.
Chen C; Louis D; Dodd T; Muecke J
Br J Ophthalmol; 2004 Jan; 88(1):17-8. PubMed ID: 14693762
[TBL] [Abstract][Full Text] [Related]
20. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Wilson MW; Hungerford JL; George SM; Madreperla SA
Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
